Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company announced that it has decided on a restructuring ...

More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Once a booming consumer-health company, 23andMe has struggled as its ambitions to become a leading healthcare company by building out the company's core product ... with co-founder and Chief Executive ...

"We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

Me has announced layoffs at the organization. It will also discontinue its therapy programs and clinical trials to refocus ...

23andMe Holding Co.'s stock turned down early Tuesday, after the DNA-testing company reported its latest quarterly loss, shedding gains made late Monday after it announced it would cut 40% of its ...

The company's CEO, Anne Wojcicki ... Additionally, seven out of eight board members resigned in September after not getting a ...

Me, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business challenges, ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” said CEO Anne Wojcicki. The ...